These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 26287921)
1. Correction: Seneca Valley Virus 3Cpro Substrate Optimization Yields Efficient Substrates for use in Peptide-Prodrug Therapy. Miles LA; Brennen WN; Rudin CM; Poirier JT PLoS One; 2015; 10(8):e0136480. PubMed ID: 26287921 [No Abstract] [Full Text] [Related]
2. Seneca Valley Virus 3Cpro Substrate Optimization Yields Efficient Substrates for Use in Peptide-Prodrug Therapy. Miles LA; Brennen WN; Rudin CM; Poirier JT PLoS One; 2015; 10(6):e0129103. PubMed ID: 26069962 [TBL] [Abstract][Full Text] [Related]
3. Correction to: Intercellular transmission of Seneca Valley virus mediated by exosomes. Xu G; Xu S; Shi X; Shen C; Hao J; Yan M; Zhang D; Zhu Z; Zhang K; Zheng H; Liu X Vet Res; 2020 Aug; 51(1):103. PubMed ID: 32811541 [TBL] [Abstract][Full Text] [Related]
4. Specificity of the polioviral proteinase 3C towards genetically engineered cleavage sites in the viral capsid. Mirzayan C; Ingraham R; Wimmer E J Gen Virol; 1991 May; 72 ( Pt 5)():1159-63. PubMed ID: 1851816 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication. Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162 [TBL] [Abstract][Full Text] [Related]
11. In vitro RNA binding of the hepatitis A virus proteinase 3C (HAV 3Cpro) to secondary structure elements within the 5' terminus of the HAV genome. Kusov YY; Gauss-Müller V RNA; 1997 Mar; 3(3):291-302. PubMed ID: 9056766 [TBL] [Abstract][Full Text] [Related]
12. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus. Ishida D; Nawa A; Tanino T; Goshima F; Luo CH; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Tsurumi T; Nishiyama Y; Kikkawa F Cancer Lett; 2010 Feb; 288(1):17-27. PubMed ID: 19604626 [TBL] [Abstract][Full Text] [Related]
13. Molecular basis for the relative substrate specificity of human immunodeficiency virus type 1 and feline immunodeficiency virus proteases. Beck ZQ; Lin YC; Elder JH J Virol; 2001 Oct; 75(19):9458-69. PubMed ID: 11533208 [TBL] [Abstract][Full Text] [Related]
15. Purification of recombinant human rhinovirus 14 3C protease expressed in Escherichia coli. Birch GM; Black T; Malcolm SK; Lai MT; Zimmerman RE; Jaskunas SR Protein Expr Purif; 1995 Oct; 6(5):609-18. PubMed ID: 8535153 [TBL] [Abstract][Full Text] [Related]
16. Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy. Knox RJ; Jenkins TC; Hobbs SM; Chen S; Melton RG; Burke PJ Cancer Res; 2000 Aug; 60(15):4179-86. PubMed ID: 10945627 [TBL] [Abstract][Full Text] [Related]
17. Cleavage of transcriptional activator Oct-1 by poliovirus encoded protease 3Cpro. Yalamanchili P; Weidman K; Dasgupta A Virology; 1997 Dec; 239(1):176-85. PubMed ID: 9426457 [TBL] [Abstract][Full Text] [Related]
18. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus]. Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371 [TBL] [Abstract][Full Text] [Related]
19. Structure-based model profiles affinity constant of drugs with hPEPT1 for rapid virtual screening of hPEPT1's substrate. Sun L; Meng S SAR QSAR Environ Res; 2016 Aug; 27(8):637-52. PubMed ID: 27586363 [TBL] [Abstract][Full Text] [Related]